Who are CYB704's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): DANICOPAN.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cyb704.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

CYB704 — Competitive Intelligence Brief

CYB704 (CYB704) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Complement Factor D inhibitor. Area: Immunology.

phase 3 Complement Factor D inhibitor Complement Factor D Immunology Biologic Live · refreshed every 30 min

Target snapshot

CYB704 (CYB704) — Sandoz. CYB704 is a selective inhibitor of complement factor D that reduces complement cascade activation and downstream inflammatory responses.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
CYB704 TARGET	CYB704	Sandoz	phase 3	Complement Factor D inhibitor	Complement Factor D
DANICOPAN	DANICOPAN		marketed	Complement Factor D Inhibitor	Complement Factor D	2024-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2035-02-25 — DANICOPAN · 9796741 · Compound · US
2038-08-02 — DANICOPAN · 12076319 · Method of Use · US

Sponsor landscape (Complement Factor D inhibitor class)

Sandoz · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CYB704 — Competitive Intelligence Brief. https://druglandscape.com/ci/cyb704. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab